Letter in response to 'The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis' by Tsai et al.
Endry H T LimAlexander P J VlaarSanne de BruinMatthijs C BrouwerDiederik van de BeekPublished in: Expert review of anti-infective therapy (2023)